BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36096316)

  • 1. Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers.
    Comandatore A; Franczak M; Smolenski RT; Morelli L; Peters GJ; Giovannetti E
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):93-100. PubMed ID: 36096316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
    Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
    Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling.
    Arora S; Singh P; Tabassum G; Dohare R; Syed MA
    Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.
    Fan J; Hitosugi T; Chung TW; Xie J; Ge Q; Gu TL; Polakiewicz RD; Chen GZ; Boggon TJ; Lonial S; Khuri FR; Kang S; Chen J
    Mol Cell Biol; 2011 Dec; 31(24):4938-50. PubMed ID: 21969607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.
    Augoff K; Hryniewicz-Jankowska A; Tabola R
    Cancer Lett; 2015 Mar; 358(1):1-7. PubMed ID: 25528630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
    Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
    Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors.
    Rizwan A; Serganova I; Khanin R; Karabeber H; Ni X; Thakur S; Zakian KL; Blasberg R; Koutcher JA
    Clin Cancer Res; 2013 Sep; 19(18):5158-69. PubMed ID: 23833310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer.
    Shi M; Cui J; Du J; Wei D; Jia Z; Zhang J; Zhu Z; Gao Y; Xie K
    Clin Cancer Res; 2014 Aug; 20(16):4370-80. PubMed ID: 24947925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.
    Fan Y; Hu D; Li D; Ma C; Tang Y; Tao Q; Deng L; Tang D
    Clin Transl Oncol; 2021 Aug; 23(8):1637-1645. PubMed ID: 33616859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
    Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
    J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer.
    Zhao D; Zou SW; Liu Y; Zhou X; Mo Y; Wang P; Xu YH; Dong B; Xiong Y; Lei QY; Guan KL
    Cancer Cell; 2013 Apr; 23(4):464-76. PubMed ID: 23523103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
    Burns JE; Hurst CD; Knowles MA; Phillips RM; Allison SJ
    Cancer Sci; 2021 Sep; 112(9):3822-3834. PubMed ID: 34181805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.
    Xie H; Hanai J; Ren JG; Kats L; Burgess K; Bhargava P; Signoretti S; Billiard J; Duffy KJ; Grant A; Wang X; Lorkiewicz PK; Schatzman S; Bousamra M; Lane AN; Higashi RM; Fan TW; Pandolfi PP; Sukhatme VP; Seth P
    Cell Metab; 2014 May; 19(5):795-809. PubMed ID: 24726384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy.
    Miao P; Sheng S; Sun X; Liu J; Huang G
    IUBMB Life; 2013 Nov; 65(11):904-10. PubMed ID: 24265197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer metabolism and mass spectrometry-based proteomics.
    Zhou W; Liotta LA; Petricoin EF
    Cancer Lett; 2015 Jan; 356(2 Pt A):176-83. PubMed ID: 24262660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
    El Sayed SM; Mohamed WG; Seddik MA; Ahmed AS; Mahmoud AG; Amer WH; Helmy Nabo MM; Hamed AR; Ahmed NS; Abd-Allah AA
    Chin J Cancer; 2014 Jul; 33(7):356-64. PubMed ID: 24636230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells.
    Yang Y; Su D; Zhao L; Zhang D; Xu J; Wan J; Fan S; Chen M
    Oncotarget; 2014 Dec; 5(23):11886-96. PubMed ID: 25361010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status and Future Perspectives of Lactate Dehydrogenase Detection and Medical Implications: A Review.
    Zhou Y; Qi M; Yang M
    Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer.
    Hanse EA; Ruan C; Kachman M; Wang D; Lowman XH; Kelekar A
    Oncogene; 2017 Jul; 36(27):3915-3924. PubMed ID: 28263970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol.
    Zhou M; Zhao Y; Ding Y; Liu H; Liu Z; Fodstad O; Riker AI; Kamarajugadda S; Lu J; Owen LB; Ledoux SP; Tan M
    Mol Cancer; 2010 Feb; 9():33. PubMed ID: 20144215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.